ibrutinib
Janssen,Abbvie
['ibru', 'cll']
#eha2023 #cll long term outcomes with ibrutinib in patients with cll. prevalence of aes of clinical interest over time p627 
Este es el Twitter del Grupo Español de Leucemia Linfocítica Crónica